NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDBrolucizumab Beovu®
(120 mg/ml solution for injection in pre-filled syringe) 		Eye, Subfoveal choroidal neovascularisation, 11.08.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Brolucizumab Brolucizumab [Specialist Drug] Eye, Retinal Disorders, Macular Degeneration, Antineovascularisation Drugs Vascular Endothelial Growth Factor Inhibitors
Brolucizumab Brolucizumab [Specialist Drug] Eye, Retinal Disorders, Macular Oedema, Antineovascularisation Drugs Vascular Endothelial Growth Factor Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
Brolucizumab (Beovu): risk of intraocular inflammation and retinal vascular occlusion increased with short dosing intervals DSU Jan 2022
NICE TA672: Brolucizumab for treating wet age-related macular degeneration
NICE TA820: Brolucizumab for treating diabetic macular oedema